ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Adenocarcinoma
Stomach Cancer
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Madrid, MD, ESP:

A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

Randomized, Open-Label Clinical Study of GB201 in Combination with Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Metastatic Pancreatic...

Enrolling
Metastatic Pancreatic Cancer
Other: Standard of care treatment options
Drug: GB201

Phase 2, Phase 3

1Globe Health Institute

Madrid, Spain and 37 other locations

authorized chemotherapeutic agent. After surgical removal of the pancreatic cancer tumor, CEB 01 will be placed in the sur ...

Enrolling
Pancreatic Carcinoma
Drug: CEB-01
Procedure: Standard surgery

Phase 2

Cebiotex

Madrid, Spain and 3 other locations

study of PBP1510 administered to patients with advanced/metastatic pancreatic cancer. The study will be conducted in two parts, Par...

Enrolling
Pancreatic Cancer
Drug: PBP1510 (400mg/16mL)
Drug: Gemcitabine (1000 mg/m^2)

Phase 1, Phase 2

Prestige Biopharma

Madrid, Spain and 3 other locations

Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Metastatic Pancreatic Cancer
Drug: nab-paclitaxel
Drug: gemcitabine

Phase 2

Astellas
Astellas

Madrid, Spain and 135 other locations

regimen gemcitabine/nab-paclitaxel in patients with metastatic pancreatic cancer who are treatment-naïve in the advanced disease se...

Active, not recruiting
Metastatic Pancreatic Cancer
Drug: Gemcitabine
Drug: OMO-103

Phase 1

Peptomyc

Madrid, Madrid, Spain and 5 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: AMG 193
Drug: Gemcitabine

Phase 1

Amgen
Amgen

Madrid, Spain and 76 other locations

Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic du...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Biological: CD40 agonist mitazalimab in combination with chemotherapy

Phase 1, Phase 2

Alligator Bioscience

Madrid, Spain and 13 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Madrid, Spain and 91 other locations

evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...

Active, not recruiting
Siewert Type 1 GEJ Cancer
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
Drug: Oxaliplatin
Drug: Futibatinib

Phase 2

Taiho Pharma
Taiho Pharma

Madrid, Spain and 21 other locations

is to assess the safety and efficacy of OncoSil™ when given in addition to standard FOLFIRINOX chemotherapy for treatment of Locally Advanced Pancreatic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: OncoSil™
Drug: FOLFIRINOX chemotherapy

Phase 2

OncoSil Medical

Madrid, Spain and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems